Newswise — Consistently sleeping less than five hours a night might raise the risk of developing depressive symptoms, according to a new genetic study led by UCL researchers.

Historically, poor sleep has been seen as a side effect of mental ill health, but this study found that the link between sleep and mental illness is more complex.

The study, published in the journal Translational Psychiatry, analysed data from people with an average age of 65 and found short sleep was associated with the onset of depressive symptoms.

Lead author Odessa S. Hamilton (UCL Institute of Epidemiology & Health Care) said: “We have this chicken or egg scenario between suboptimal sleep duration and depression, they frequently cooccur, but which comes first is largely unresolved. Using genetic susceptibility to disease we determined that sleep likely precedes depressive symptoms, rather than the inverse.”

For the study, the researchers used genetic and health data from 7,146 people recruited by the English Longitudinal Study of Ageing (ELSA), a nationally representative population study in England.

They found that people with a stronger genetic predisposition to short sleep (less than five hours in a given night) were more likely to develop depressive symptoms over 4-12 years, but that people with a greater genetic predisposition to depression did not have an increased likelihood of short sleep.

Senior author Dr Olesya Ajnakina (UCL Institute of Epidemiology & Health Care and the Institute of Psychiatry, Psychology & Neuroscience at King’s College London) said: “Short and long sleep durations, along with depression, are major contributors to public health burden that are highly heritable. Polygenic scores, indices of an individual’s genetic propensity for a trait, are thought to be key in beginning to understand the nature of sleep duration and depressive symptoms.”

The researchers assessed the strength of genetic predisposition among the ELSA participants using findings from previous genome-wide association studies that have identified thousands of genetic variants linked to a higher likelihood of developing depression and short or long sleep.

As part of a number of separate analyses to investigate the robustness of their results, the research team also looked at non-genetic associations between depressive symptoms and sleep duration.

They found that people sleeping five hours or less were 2.5 times more likely to develop depressive symptoms, while people with depressive symptoms were a third more likely to suffer from short sleep. They adjusted for a rich selection of factors that could affect the results such as education, wealth, smoking status, physical activity and limiting longstanding illness.

The researchers also found a link between sleeping long and developing depressive symptoms, with participants sleeping longer than nine hours being 1.5 times more likely to develop depressive symptoms than those who sleep an average of seven hours. However, depressive symptoms were not associated with sleeping longer four to 12 years later, which corresponded to the genetic findings.

Professor Andrew Steptoe (Head of Behavioural Science and Health, UCL Institute of Epidemiology & Health Care) said: “Suboptimal sleep and depression increase with age, and with the worldwide phenomenon of population ageing there is a growing need to better understand the mechanism connecting depression and a lack of sleep. This study lays important groundwork for future investigations on the intersection of genetics, sleep, and depressive symptoms.”

Overall, the participants in the study had an average of seven hours’ sleep a night. More than 10% slept for less than five hours a night at the start of the study period, rising to over 15% at the end of the study period, and the proportion of participants classed as having depressive symptoms increased by ~3 percentage points, from 8.75-11.47%.

Both sleep duration and depression are partly inherited from one generation to the next. Earlier twin studies have suggested depression is about 35% heritable, and that genetic differences account for 40% of the variance in sleep duration.

In the study, data on sleep and depressive symptoms were combined from two ELSA surveys conducted two years apart, as sleep duration and depression are known to fluctuate over time.

Notes to Editors

For more information or to speak to the researchers, please contact Mark Greaves, UCL Media Relations. T: +44 (0)7985 208 992, E: [email protected]

Odessa S. Hamilton, Andrew Steptoe, Olesya Ajnakina, “Polygenic Predisposition, Sleep Duration, and Depression: Evidence from a Prospective Population-Based Cohort” will be published in Nature, Translational Psychiatry on Friday 20 October 2023, 01:00 UK time / Thursday 19 October 2023, 20:00 US Eastern time and is under a strict embargo until this time

DOI: 10.1038/s41398-023-02622-z

Post-embargo link: nature.com/s41398-023-02622-z

About UCL – London’s Global University

UCL is a diverse global community of world-class academics, students, industry links, external partners, and alumni. Our powerful collective of individuals and institutions work together to explore new possibilities.

Since 1826, we have championed independent thought by attracting and nurturing the world's best minds. Our community of more than 50,000 students from 150 countries and over 16,000 staff pursues academic excellence, breaks boundaries and makes a positive impact on real world problems.

The Times and Sunday Times University of the Year 2024, we are consistently ranked among the top 10 universities in the world and are one of only a handful of institutions rated as having the strongest academic reputation and the broadest research impact.

We have a progressive and integrated approach to our teaching and research – championing innovation, creativity and cross-disciplinary working. We teach our students how to think, not what to think, and see them as partners, collaborators and contributors.  

For almost 200 years, we are proud to have opened higher education to students from a wide range of backgrounds and to change the way we create and share knowledge.

We were the first in England to welcome women to university education and that courageous attitude and disruptive spirit is still alive today. We are UCL.

www.ucl.ac.uk | Follow @uclnews on Twitter | Read news at www.ucl.ac.uk/news/ | Listen to UCL podcasts on SoundCloud | View images on Flickr | Find out what’s on at UCL Minds

About King’s College London and the Institute of Psychiatry, Psychology & Neuroscience 

King’s College London is amongst the top 35 universities in the world and top 10 in Europe (THE World University Rankings 2023), and one of England’s oldest and most prestigious universities.

With an outstanding reputation for world-class teaching and cutting-edge research, King’s maintained its sixth position for ‘research power’ in the UK (2021 Research Excellence Framework).

King's has more than 33,000 students (including more than 12,800 postgraduates) from some 150 countries worldwide, and some 8,500 staff. The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s is a leading centre for mental health and neuroscience research in Europe. It produces more highly cited outputs (top 1% citations) on psychiatry and mental health than any other centre (SciVal 2021), and on this metric has risen from 16th (2014) to 4th (2021) in the world for highly cited neuroscience outputs. In the 2021 Research Excellence Framework (REF), 90% of research at the IoPPN was deemed ‘world leading’ or ‘internationally excellent’ (3* and 4*). World-leading research from the IoPPN has made, and continues to make, an impact on how we understand, prevent and treat mental illness, neurological conditions, and other conditions that affect the brain.